The US import of opacifying preparations, X-ray, diagnostic reagents is projected to grow steadily from 2024 to 2028, starting at $1.0565 billion to $1.1495 billion. In 2023, the import was valued at approximately $1.030 billion, indicating a consistent upward trend with an annual growth rate. The year-on-year growth shows a stable increase, with compound annual growth rate (CAGR) over this period reflecting robust demand in the medical diagnostics field. Factors such as technological advancements and increasing healthcare spending may support future growth.
Future trends to watch include:
- Technological advancements in diagnostic imaging techniques.
- Regulatory changes affecting import policies.
- Growing demand within healthcare innovations and expansions.
- Global supply chain influences impacting import dynamics.
